ProNephro (NGAL) now available through Roche Diagnostics.

Search

Announcements

Subscribe to investor news

Investor News

BioPorto

BioPorto A/S

Notice convening the Annual General Meeting in BioPorto A/S

Thu, 26 Mar 2026 08:00 GMT

BioPorto

BioPorto A/S

Indkaldelse til ordinær generalforsamling i BioPorto A/S

Thu, 26 Mar 2026 08:00 GMT

BioPorto

BioPorto A/S

BioPorto announces the Annual Report for 2025

Thu, 26 Mar 2026 06:43 GMT

BioPorto

BioPorto A/S

BioPorto annoncerer Årsrapporten for 2025

Thu, 26 Mar 2026 06:43 GMT

BioPorto

BioPorto A/S

BioPorto Successfully Completes Preliminary Analysis of U.S. Adult NGAL Cutoff Study; Pre-Submission expected by End of Q1 2026

Wed, 18 Mar 2026 17:55 GMT

Follow this link to view all historical announcements.

Follow this link to view all historical announcements.